Liver-Derived Endothelial Cells, human, passage 2
Liver-Derived Endothelial Cells, human, passage 2
Human Liver-Derived Endothelial Cells
Note: Product will be discontinued follow depletion of current inventory. HLECP1 is the equivalent replacement.
You May Also Need...
Product Overview
Endothelial cells are the primary barrier cells that line blood vessels and sinusoids of the liver. Human Liver-derived Endothelial Cells (HLECs) are isolated and enriched from liver tissue, then cryopreserved for use in a wide range of research models.
HLECs are characterized for markers of endothelial cells, including CD31, vWF, and LYVE-1 as shown by flow cytometry and maintain appropriate endothelial morphology over limited serial passaging. Human liver-derived endothelial cells are derived from whole livers leading to a mixed population of vascular endothelial cells and sinusoidal endothelial cells.
The recommended medium for HLECs is EGMTM 2 which is optimized for endothelial cell health and growth.
Request More InfoBenefits
Low passage
Applications
- ADMETox
- Liver Disease
- NASH
Storage and Content
- Cryo Vial >800,000 cells
SDS, CoA, and Instructions
Safety Data Sheets (SDS)
Choose a language to view the SDS.
Certificate of Analysis (CoA)
Please enter Lot Number, including all zeros, located on the product label and please take into account that it is case sensitive.
The Importance of Cell-subtype Selection in Creation of a 3D Liver Fibrosis Model
Data sheet detailing 3D liver fibrosis model in collaboration with Visikol